A Vision Transformer-Based Framework for Knowledge Transfer From Multi-Modal to Mono-Modal Lymphoma Subtyping Models-Reference-Cited by-同舟云学术

A Vision Transformer-Based Framework for Knowledge Transfer From Multi-Modal to Mono-Modal Lymphoma Subtyping Models

Published:2024-09 Issue:9 Volume:28 Page:5562-5572
ISSN:2168-2194
Container-title:IEEE Journal of Biomedical and Health Informatics
language:
Short-container-title:IEEE J. Biomed. Health Inform.

Author:

Guetarni Bilel¹^ORCID,Windal Feryal¹^ORCID,Benhabiles Halim²^ORCID,Petit Marianne³,Dubois Romain³,Leteurtre Emmanuelle³^ORCID,Collard Dominique⁴^ORCID

Affiliation:

1. Junia, University of Lille, CNRS, Centrale Lille, University of Polytechnique Hauts-de-France, Lille, France

2. IMT Nord Europe, Institut Mines-Télécom, Université de Lille, Center for Digital Systems, Lille, France

3. Department of Pathology, University Hospital of Lille, Lille, France

4. LIMMS/CNRS-IIS, IRL 2820, The University of Tokyo, Tokyo, Japan

Funder

National Research Agency of France

Publisher

Institute of Electrical and Electronics Engineers (IEEE)

Link

http://xplorestaging.ieee.org/ielx8/6221020/10666866/10543042.pdf?arnumber=10543042

Reference50 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Epidemiology of diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) in the United States and Western Europe: population-level projections for 2020–2025

3. Accurate Classification of Germinal Center B-Cell–Like/Activated B-Cell–Like Diffuse Large B-Cell Lymphoma Using a Simple and Rapid Reverse Transcriptase–Multiplex Ligation-Dependent Probe Amplification Assay

4. Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

5. ROBUST: A Phase III Study of Lenalidomide Plus R-CHOP Versus Placebo Plus R-CHOP in Previously Untreated Patients With ABC-Type Diffuse Large B-Cell Lymphoma